First Trust Advisors LP Astrazeneca PLC Transaction History
First Trust Advisors LP
- $95 Billion
- Q2 2024
A detailed history of First Trust Advisors LP transactions in Astrazeneca PLC stock. As of the latest transaction made, First Trust Advisors LP holds 870,741 shares of AZN stock, worth $66.2 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
870,741
Previous 1,231,576
29.3%
Holding current value
$66.2 Million
Previous $83.4 Million
18.61%
% of portfolio
0.07%
Previous 0.09%
Shares
19 transactions
Others Institutions Holding AZN
# of Institutions
1,343Shares Held
492MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.94 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.24 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.08 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.79 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.34 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $236B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...